In lung adenocarcinoma cells, knocking down LCMR1 reduces cell proliferation and tumorigenesis [10,11,12]; yet its role in LCLC, where it was originally identified, remains to be established [13,14]. Here, MED19 is linked to lung adenocarcinoma.